These include mutations in the gene encoding COSMC resulting in loss of T synthase activity [15], hypermethylation of COSMC in pancreatic cancer [16] and relocation of polypeptide GalNAc transferases to the ER [17]. This evidence concerns the gene C1GALT1C1 and familial pancreatic carcinoma.